ES554503A0 - Procedimiento para preparar derivados de 2-amino-tiazol - Google Patents

Procedimiento para preparar derivados de 2-amino-tiazol

Info

Publication number
ES554503A0
ES554503A0 ES554503A ES554503A ES554503A0 ES 554503 A0 ES554503 A0 ES 554503A0 ES 554503 A ES554503 A ES 554503A ES 554503 A ES554503 A ES 554503A ES 554503 A0 ES554503 A0 ES 554503A0
Authority
ES
Spain
Prior art keywords
amino
alkyl
group
hydrogen atom
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554503A
Other languages
English (en)
Other versions
ES8900045A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Chauvin SAS
Original Assignee
Laboratoires Chauvin Blache SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Chauvin Blache SA filed Critical Laboratoires Chauvin Blache SA
Publication of ES554503A0 publication Critical patent/ES554503A0/es
Publication of ES8900045A1 publication Critical patent/ES8900045A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES554503A 1985-04-30 1986-04-29 Procedimiento para preparar derivados de 2-amino-tiazol Expired ES8900045A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8506568A FR2581063B1 (fr) 1985-04-30 1985-04-30 Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ES554503A0 true ES554503A0 (es) 1988-11-16
ES8900045A1 ES8900045A1 (es) 1988-11-16

Family

ID=9318828

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554503A Expired ES8900045A1 (es) 1985-04-30 1986-04-29 Procedimiento para preparar derivados de 2-amino-tiazol

Country Status (11)

Country Link
US (1) US4785008A (es)
EP (1) EP0202157B1 (es)
JP (1) JPH0629270B2 (es)
AT (1) ATE45734T1 (es)
CA (1) CA1289144C (es)
DE (1) DE3665176D1 (es)
DK (1) DK168523B1 (es)
ES (1) ES8900045A1 (es)
FR (1) FR2581063B1 (es)
IE (1) IE59141B1 (es)
PT (1) PT82480B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504278A (ja) * 1944-06-01 1997-04-28 ザ、ウェルカム、ファンデーション、リミテッド Ｎｏシンターゼインヒビターとしての置換尿素およびイソチオ尿素誘導体
EP0254259A3 (en) * 1986-07-21 1989-11-23 Otsuka Pharmaceutical Factory, Inc. P-aminophenol derivatives
JPS6339868A (ja) * 1986-08-04 1988-02-20 Otsuka Pharmaceut Factory Inc ジ低級アルキルフエノ−ル誘導体
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
WO1990009985A1 (en) * 1989-02-23 1990-09-07 Otsuka Pharmaceutical Factory, Inc. p-AMINOPHENOL DERIVATIVE AND PRODUCTION AND APPLICATION THEREOF
JPH03111178U (es) * 1990-02-27 1991-11-14
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
US6100282A (en) * 1998-01-02 2000-08-08 Hoffman-La Roche Inc. Thiazole derivatives
ATE365158T1 (de) * 1999-04-28 2007-07-15 Inst Med Molecular Design Inc Pyrimidincarbonsäurederivate
BR0013899A (pt) * 1999-09-10 2003-07-08 Merck & Co Inc Composto, composição farmacêutica, processos de tratamento ou prevenção de câncer, de uma doença em que a angiogênese esteja implicada, da vascularização retinal, da retinopatia diabética, da degeneração macular relacionada a idade, de doenças inflamatórias, de uma doença ou condições dependentes da tirosina quinase, de patologias associadas com ossos, e, processos para produzir uma composição farmacêutica, e de reduzir ou prevenir dano tecidual em seguida a um evento isquêmico cerebral
WO2007002461A1 (en) * 2005-06-23 2007-01-04 Dr. Reddy's Laboratories Ltd. 3,4-substituted thiazoles as ampk activators
BRPI0613555A2 (pt) * 2005-07-04 2011-01-18 Reddys Lab Ltd Dr derivados de tiazóis como ativador de ampk
BRPI0906023A2 (pt) * 2008-03-19 2015-06-30 Bayer Cropscience Ag "composto derivado de hidroximoiltetrazol, compostos e método de controle dos fungos fitopatogênicos ou insetos daninhos de plantas, safras ou sementes"
US10696638B2 (en) 2017-12-26 2020-06-30 Industrial Technology Research Institute Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same
KR20210015892A (ko) 2018-05-29 2021-02-10 세르시 테라퓨틱스 인코포레이티드 통증 치료를 위한 화합물, 이를 포함하는 조성물 및 이를 사용하는 방법
CA3136102A1 (en) 2019-05-10 2020-11-19 Cersci Therapeutics, Inc. Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent
CN118546107A (zh) * 2024-05-15 2024-08-27 中国药科大学 一类2-噻唑氨基苯酚衍生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264710A (es) * 1960-05-13
US3299087A (en) * 1961-04-24 1967-01-17 Geigy Chem Corp Nu, nu'-bis-(thiazolyl)-phenylenediamines
US3467666A (en) * 1966-11-07 1969-09-16 Geigy Chem Corp 2-substituted aminothiazoles
BE795907A (fr) * 1972-02-25 1973-06-18 Luso Farmaco Inst 2-amino-4-arylthiazoles 5-substitues et leur preparation
JPS565747B2 (es) * 1973-10-24 1981-02-06
JPS5742629B2 (es) * 1973-10-29 1982-09-09
JPS5833870B2 (ja) * 1976-01-12 1983-07-22 塩野義製薬株式会社 チアゾリン誘導体
DK150068C (da) * 1978-06-02 1987-06-29 Pfizer Analogifremgangsmaade til fremstilling af aminothiazoler

Also Published As

Publication number Publication date
DK197786D0 (da) 1986-04-30
DE3665176D1 (en) 1989-09-28
IE59141B1 (en) 1994-01-12
EP0202157A1 (fr) 1986-11-20
IE861119L (en) 1986-10-30
CA1289144C (en) 1991-09-17
US4785008A (en) 1988-11-15
ATE45734T1 (de) 1989-09-15
FR2581063B1 (fr) 1987-07-17
FR2581063A1 (fr) 1986-10-31
JPS6277375A (ja) 1987-04-09
JPH0629270B2 (ja) 1994-04-20
EP0202157B1 (fr) 1989-08-23
DK197786A (da) 1986-10-31
DK168523B1 (da) 1994-04-11
ES8900045A1 (es) 1988-11-16
PT82480A (en) 1986-05-01
PT82480B (pt) 1988-03-03

Similar Documents

Publication Publication Date Title
DE3665176D1 (en) N-substituted 2-amino-thiazoles, process for their preparation and their therapeutical use
DK245888A (da) 4-aminoquinolinderivater
MX9504332A (es) Derivados de amino(tio)eter y procedimiento para su preparacion.
MX9306831A (es) Nuevos compuestos heterociclicos.
ES541668A0 (es) Un procedimiento para preparar derivados de dihidropiridina
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
DK0464465T3 (da) Substituerede aminoalkylbiphenylderivater, antimykotiske præparater indeholdende disse derivater og mellemprodukter til fremstilling deraf
NO882334D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
ES512574A0 (es) "procedimiento de preparacion de derivados carboxilato".
DE3464603D1 (en) 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acid derivatives, processes for the preparation thereof, and antiallergic agent containing the same
ES493308A0 (es) Procedimiento de preparacion de nuevos derivados n-sustitui-dos de tetrahidropiridinil-indol
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
DK540684A (da) Benzoquinoliziner
DK159924C (da) Pyridooe1,2-aaapyrimidinderivater, fremgangsmaade til deres fremstilling samt farmaceutisk praeparat til behandling af allergiske sygdomme indeholdende derivaterne
NO870251L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
PT82847B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 4-amino-2-(imidazolodina-2-ona-1-il)-pirimidina-5-carboxil-(n-(3-trifluormetil-fenil)-amidas)
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine
ES8101045A1 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos
NO870250L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
DK554688A (da) Farmaceutisk aktive derivater af (r)-5-pentyl-amino-5-oxopentansyre og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
SU1783774A1 (ru) Натриевая соль n-(3-хлорбутен-2-ил)антраниловой кислоты, проявляющая противовоспалительную и анальгетическую активность
FI850593L (fi) N-(2,6-disubstituerade aromatiska) -n'-pyridinylureafoereningar.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001102